Back to Oncology
Oncologyv2011Evidence-Based

Cancer and Aging Research Group Chemotherapy Toxicity Tool (CARG-TT)

The CARG-TT estimates the risk of severe chemotherapy-related side effects (Grade 3 or greater toxicity) in older cancer patients (age >65). It uses 11 geriatric assessment variables, laboratory values, and patient characteristics to predict chemotherapy toxicity risk.

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
carg tt score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Cancer and Aging Research Group Chemotherapy Toxicity Tool (CARG-TT) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within oncology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Score = (2 × age_72_or_older) + (2 × gi_gu_cancer) + (2 × standard_dose_chemo) + (2 × polychemotherapy) + (3 × hemoglobin_low) + (3 × creatinine_clearance_low) + (2 × hearing_impaired) + (3 × falls_past_6_months) + (1 × medication_assistance) + (2 × walking_limited) + (1 × social_activity_decreased)

Clinical Pearls & Practice Notes

  • Use in cancer patients aged 65 years or older undergoing chemotherapy
  • Hemoglobin thresholds: males <11 g/dL, females <10 g/dL
  • Creatinine clearance calculated using Cockcroft-Gault equation
  • Standard dose = 100% of published dose, reduced dose = <100%
  • Polychemotherapy = combination of >1 chemotherapy drug
  • Score ranges from 0 to 23 points
  • Recommended by ASCO guidelines for geriatric oncology assessment
  • Based on prospective study of 500 patients aged ≥65 years
  • Grade ≥3 toxicity defined by Common Terminology Criteria for Adverse Events (CTCAE)

Evidence & Literature Citations

  1. Hurria A, Togawa K, Mohile SG, Owusu C, Klepin HD, Gross CP, et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol. 2011 Sep 1;29(25):3457-65. doi: 10.1200/JCO.2011.34.7625.
  2. Magnuson A, Sattar S, Nightingale G, Saracino R, Skoneczka J, Trevino KM, et al. A practical guide to geriatric syndromes in older adults with cancer: A focus on falls, cognition, polypharmacy, and depression. Am Soc Clin Oncol Educ Book. 2019 Jan;39:e96-e109. doi: 10.1200/EDBK_237641.
  3. Extermann M, Boler I, Reich RR, Lyman GH, Brown RH, DeFelice J, et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer. 2012 Jul 1;118(13):3377-86. doi: 10.1002/cncr.26646.

Score Interpretation Ranges

Low Risk0 – 5 pts

30% risk of grade ≥3 toxicity

Intermediate Risk6 – 9 pts

52% risk of grade ≥3 toxicity

High Risk10 – 23 pts

83% risk of grade ≥3 toxicity

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.